Study to Confirm the Efficacy and Safety of Fixed-dose Combinations of Amlodipine and Candesartan
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 210 participants.
Also called NCT03231982
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 210 participants
- Sponsor
- Registry
-
NCT03231982
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT03231982. Randomized; quadruple masking; primary purpose treatment. Start 2017-04-17 (actual); primary completion 2019-04-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study to Confirm the Efficacy and Safety of Fixed-dose Combinations of Amlodipine and Candesartan
- Acronym
- MACH
- Condition
- Hypertension
- Intervention (Drug)
- Group I
- Intervention (Drug)
- Group II
- Lead sponsor
- HK inno.N Corporation
Record details
- Record id
cardio:ct-nct03231982- Content hash
26dabed1ce6764c30b538f64fbc460419539ac9fd21b53db19df9bbfbe0bb295